News Releases
- August 29, 2022Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer
- August 24, 2022Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson's Disease
- August 8, 2022Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update
- May 4, 2022Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
- April 28, 2022Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging
- April 11, 2022Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease
Media Coverage
Events & Presentations
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top